Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

The Development Of NSAID HNO Donor For Cancer And Heart Disease

  • Read more about The Development Of NSAID HNO Donor For Cancer And Heart Disease
US Application 61/349,716
Filed on 2010-05-28

Compositions and Methods for Treating Inflammatory Conditions

  • Read more about Compositions and Methods for Treating Inflammatory Conditions
US Application 61/355,965
Filed on 2010-06-17

Regulation Of Skin Pigmentation By Neuregulin-I (NRG-1)

  • Read more about Regulation Of Skin Pigmentation By Neuregulin-I (NRG-1)
US Application 61/357,846
Filed on 2010-06-23

Linked Purine Pterin HPPK Inbibitors Useful As Antibacterial Agents

  • Read more about Linked Purine Pterin HPPK Inbibitors Useful As Antibacterial Agents
US Application 61/356,213
Filed on 2010-06-18

Specimen F2PE (Specimen Fit-For-Purpose Evaluator)

  • Read more about Specimen F2PE (Specimen Fit-For-Purpose Evaluator)
US Application 61/333,900
Filed on 2010-05-12

Soluble Glypican-3 Inhibits Cancer Growth

  • Read more about Soluble Glypican-3 Inhibits Cancer Growth
US Application 61/334,135
Filed on 2010-05-12

Cross-reactive HIV-1 Neutralizing Human Monoclonal Antibodies M66 Targeting The Gp41 MPER

  • Read more about Cross-reactive HIV-1 Neutralizing Human Monoclonal Antibodies M66 Targeting The Gp41 MPER
US Application 61/272,349
Filed on 2009-09-16

Diagnostic And Therapeutic Applications Of MicroRNAs Aberrantly Regalated In Lung Cancers From Never-smokers

  • Read more about Diagnostic And Therapeutic Applications Of MicroRNAs Aberrantly Regalated In Lung Cancers From Never-smokers
US Application 61/155,709
Filed on 2009-02-26

Peptide Inhibitors Of Interferon Gamma And Interleukin 10 Signaling

  • Read more about Peptide Inhibitors Of Interferon Gamma And Interleukin 10 Signaling
US Application 61/333,512
Filed on 2010-05-11

A New Method For The Construction Of Anti-HER2 IgY Antibody Functionalized Single-walled Carbon Nanotubes With Improved Properties For Detection And Selective Destruction Of Breast Cancer Cells

  • Read more about A New Method For The Construction Of Anti-HER2 IgY Antibody Functionalized Single-walled Carbon Nanotubes With Improved Properties For Detection And Selective Destruction Of Breast Cancer Cells
US Application 61/310,324
Filed on 2010-03-04

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 116
  • Page 117
  • Page 118
  • Page 119
  • Page 120
  • Page 121
  • Page 122
  • Page 123
  • Page 124
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health